Highline Wealth Partners LLC Nuvation Bio Inc. Transaction History
Highline Wealth Partners LLC
- $372 Billion
- Q3 2025
A detailed history of Highline Wealth Partners LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Highline Wealth Partners LLC holds 13,000 shares of NUVB stock, worth $61,490. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,000
Previous 13,000
-0.0%
Holding current value
$61,490
Previous $25.4 Million
89.74%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
193Shares Held
168MCall Options Held
2.31MPut Options Held
221K-
Decheng Capital LLC Menlo Park, CA26MShares$123 Million12.78% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$76.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$73.1 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA11MShares$52.2 Million46.36% of portfolio
-
Laurion Capital Management LP New York, NY10.2MShares$48.4 Million0.37% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $1.03B
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...